France

BMI View: Dialogue between firms, regulators and payers will become more common as the communication of product value becomes increasingly important. Regulatory agencies that make reimbursement... 2012-05-18

BMI View: Sanofi's focus on emerging market expansion via the acquisition of local companies is a commendable strategy for increasing its revenue streams in non-traditional markets.... 2012-03-12

BMI View: Despite concerted progress made on the fiscal consolidation front in the first half of 2011, the French government's medium-term fiscal targets remain on the optimistic side,... 2012-02-07

BMI View: Despite concerted progress made on the fiscal consolidation front in the first half of the year, the French government's medium-term fiscal targets remain on the optimistic... 2011-11-15

BMI View: While Sanofi's share price movements have aligned with that of the pharma 20 index over the past 12 months, BMI believes that over the next 12 months investor perception regarding... 2011-11-03

BMI View: Sanofi's acquisition of Universal Medicare's over-the-counter business, its fourth purchase of a consumer healthcare company since the start of 2010, reinforces the company's... 2011-08-25

CFW View: Sanofi's acquisition of Universal Medicare's over-the-counter business, its fourth purchase of a consumer healthcare company since the start of 2010, reinforces the company's... 2011-08-25

BMI View: Dialogue between firms, regulators and payers will become more common as the communication of product value becomes increasingly important. Regulatory agencies that make reimbursement... 2011-08-23

BMI View: Sanofi's share price will outperform BMI's Pharma 20 Index over the next three months. The company's Q211 results illustrate its high exposure to healthcare sector cost-containment... 2011-08-01

BMI view: Deficits remain a key challenge for the majority of governments across Europe. While many sectors may see only limited downside risks from the situation, the pharmaceutical... 2011-07-25